Apogee Therapeutics data show long-acting eczema drug induced relief with less frequent injections
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Data from Apogee Therapeutics indicates that its long-acting eczema drug has induced relief with less frequent injections. The company's work on long-acting autoimmune drugs has reportedly drawn significant interest, with a potential acquisition by AbbVie. The value of the potential deal is substantial, but details of the transaction and its outcome are unclear.